Biostax Corp (BTAX)

[locicat1]

I have been and will continue to be resolute about pounding home to all posters who are shareholders the absolute necessity to have FDA sanctioned clinical studies done. If anything,the HIV Plus Magazine article serves to underline the unfortunate fact that LDN studies for therapy in Crohn's Disease at the FDA under the IND of IMUN should have been completed long ago. Now, as of January of 2018 another purported FDA Meeting was held and follow up minutes/guidance purportedly received by the FDA. Now what? Have the study protocols even been designed-let alone the studies started? How could they be-no Chief Medical Officer (CMO) and a continuing unqualified CEO.
Need to have the funding in place- and not a few hundred thousand here and a few hundred thousand there sold at literally pennies on the dollar and diluting the blazes out of the OS. That is not how a competent Biotechnology company with significant potential operates. And why has this continued??